I now have solid textbook evidence. Let me compile the full answer.
Azithromycin vs. Amoxiclav for Tonsillitis - Full Breakdown
First, the most important point: Should you take either on your own?
No - please do not self-medicate. Here's why:
- About 50-80% of sore throats/tonsillitis cases are viral (caused by viruses like EBV, adenovirus, rhinovirus). Antibiotics do nothing for these and will only cause side effects and contribute to antibiotic resistance.
- Even for bacterial tonsillitis, the wrong antibiotic can fail to clear the infection and leave you worse off.
- A doctor needs to examine you, possibly do a rapid strep test or throat swab, and confirm whether you actually have bacterial (Group A Streptococcal/GABHS) tonsillitis before prescribing anything.
Which is better: Azithromycin or Amoxiclav?
Here's the evidence-based hierarchy straight from the textbooks:
First-Line: Penicillin or Amoxicillin (plain, NOT Amoxiclav)
According to Tintinalli's Emergency Medicine and Cummings Otolaryngology:
"No clinical isolate of GABHS has been documented to be penicillin resistant; thus, it remains the treatment of choice based on its efficacy, safety, narrow spectrum, ease of dosing, compliance, and cost."
A 10-day course of penicillin or amoxicillin (plain) is the standard first-line treatment for confirmed bacterial GABHS tonsillitis. The antibiotics work to:
- Shorten duration of illness
- Prevent spread
- Prevent complications (peritonsillar abscess, sinusitis, otitis media)
- Prevent rheumatic fever
Second-Line: Amoxiclav (amoxicillin + clavulanate)
Amoxiclav is used when:
- Plain penicillin/amoxicillin has already failed (treatment failure occurs in 7-37% of cases)
- The failure is suspected to be due to beta-lactamase-producing bacteria in the tonsil that break down plain penicillin
As Cummings states:
"Cephalosporins, clindamycin, and amoxicillin/clavulanic acid are all preferred for penicillin failures."
So Amoxiclav is stronger and broader - it's a step up, not the starting point.
Third-Line / Penicillin Allergy: Azithromycin (and other macrolides)
According to multiple textbooks:
"For those who are penicillin allergic, a first-generation cephalosporin, clindamycin, clarithromycin, or azithromycin are first-line treatments."
However, there's a major caveat - macrolide resistance is rising:
"Macrolide resistance is increasing worldwide. Currently, 6-7% of GABHS isolates in the United States are macrolide resistant."
Azithromycin's short 5-day course is convenient, but if the bacteria in your throat are resistant, it simply won't work.
Head-to-Head Comparison
| Feature | Azithromycin | Amoxiclav |
|---|
| Role | Penicillin allergy alternative | Penicillin failure / broader coverage |
| Spectrum | Macrolide (gram-positive, atypicals) | Beta-lactam + beta-lactamase inhibitor (broader) |
| Duration | 5 days | 7-10 days |
| Resistance risk | Higher (macrolide resistance increasing) | Lower for GABHS |
| GI side effects | Moderate (nausea, diarrhea) | More common (nausea, diarrhea, diarrhea) |
| Who it's for | Penicillin-allergic patients | Penicillin treatment failures |
| Coverage | GABHS + atypicals (Mycoplasma, etc.) | GABHS + beta-lactamase producers |
Bottom line: Amoxiclav is generally more reliable than azithromycin for bacterial tonsillitis, but neither should be your first choice - plain amoxicillin or penicillin is still first-line, and it's cheaper with a narrower spectrum (which is better antibiotic stewardship).
Practical Advice
- See a doctor - get a throat swab or rapid strep test done
- If bacterial GABHS is confirmed: expect plain amoxicillin or penicillin for 10 days
- If you're penicillin-allergic: azithromycin or clarithromycin is appropriate
- If you've already tried penicillin and it failed: Amoxiclav is the upgrade
- Complete the full course - stopping early leads to recurrence and resistance
Sources: Cummings Otolaryngology Head and Neck Surgery; Tintinalli's Emergency Medicine (A Comprehensive Study); Schwartz's Principles of Surgery. Recent 2024 Italian consensus guidelines (
PMID 39501298) and a 2025 Lancet umbrella review (
PMID 39243792) on antibiotic duration further support these recommendations.